Since 2015, GPX Medical has coordinated a three-year research project funded through the European Eurostars Program – Neo-Lung. Collaborative partners in the project have been Lund University in Sweden, the Norwegian company Norsk Elektro Optikk, and the German laser company Nanoplus. The project is officially closed on 31 December 2018, but on 19-20 November, a final meeting of the project was held in Lund. At the same time, a clinical study is concluded as part of the project at Skåne University Hospital in Lund. The project has been a great success and there are now plans for further cooperation.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to GASPOROX AB (publ), with the aim to develop and commercialize medical applications of GASMAS technology. The company is owned to 60% by GASPOROX AB (publ) and to 40% by Norsk Elektro Optikk AS, and located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB
Maskinvägen 1
227 30 Lund